References

References1. Juurlink DN, Mamdani MM, Kopp A, et al. The risk of suicide with selective serotonin reuptake inhibitors in the elderly. Am J Psychiatry 2006;163:813–821.JuurlinkDN]]MamdaniMM]]KoppA&etal;The risk of suicide with selective serotonin reuptake inhibitors in the elderly.Am J Psychiatry2006163813-8212. Fergusson D, Doucette S, Glass KC, et al. Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomized controlled trials. BMJ 2005;330:396.FergussonD]]DoucetteS]]GlassKC&etal;Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomized controlled trials.BMJ20053303963. Jick H, Kaye JA, Jick SS. Antidepressants and the risk of suicidal behaviors. JAMA 2004;292:338–343.JickH]]KayeJA]]JickSSAntidepressants and the risk of suicidal behaviors.JAMA2004292338-3434. Khan A, Khan S, Kolts R, et al. Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports. Am J Psychiatry 2003;160:790–792.KhanA]]KhanS]]KoltsR&etal;Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports.Am J Psychiatry2003160790-7925. Simon GE, Savarino J. Suicide attempts among patients starting depression treatment with medications or psychotherapy. Am J Psychiatry 2007;164:1029–1034.SimonGE]]SavarinoJSuicide attempts among patients starting depression treatment with medications or psychotherapy.Am J Psychiatry20071641029-10346. Simon GE, Savarino J, Operskalski B, et al. Suicide risk during antidepressant treatment. Am J Psychiatry 2006;163:41–47.SimonGE]]SavarinoJ]]OperskalskiB&etal;Suicide risk during antidepressant treatment.Am J Psychiatry200616341-477. Gunnell D, Saperia J, Ashby D. Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomized controlled trials submitted to the MHRA’s safety review. BMJ 2005;330:385.GunnellD]]SaperiaJ]]AshbyDSelective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomized controlled trials submitted to the MHRA’s safety review.BMJ20053303858. Martinez C, Rietbock S, Wise L, et al. Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study. BMJ 2005;330:389.MartinezC]]RietbockS]]WiseL&etal;Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study.BMJ20053303899. Tiihonen J, Lönnqvist J, Wahlbeck K, et al. Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort. Arch Gen Psychiatry 2006;63:1358–1367.TiihonenJ]]LönnqvistJ]]WahlbeckK&etal;Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort.Arch Gen Psychiatry2006631358-136710. Gibbons RD, Brown CH, Hur K, et al. Early evidence on the effects of regulators’ suicidality warnings on SSRI prescriptions and suicide in children and adolescents. Am J Psychiatry 2007;164:1356–1363.GibbonsRD]]BrownCH]]HurK&etal;Early evidence on the effects of regulators’ suicidality warnings on SSRI prescriptions and suicide in children and adolescents.Am J Psychiatry20071641356-136311. Valuck RJ, Libby AM, Orton HD, et al. Spillover effects on treatment of adult depression in primary care after FDA advisory on risk of pediatric suicidality with SSRIs. Am J Psychiatry 2007;164:1198–1205.ValuckRJ]]LibbyAM]]OrtonHD&etal;Spillover effects on treatment of adult depression in primary care after FDA advisory on risk of pediatric suicidality with SSRIs.Am J Psychiatry20071641198-120512. Benkert O, Hippius H. Psychiatrische Pharmakotherapie. Berlin Heidelburg, New York, Springer, 1980, p 35.BenkertO]]HippiusHPsychiatrische Pharmakotherapie.Berlin Heidelburg, New YorkSpringer19803513. Feuerstein TJ, Jackisch R. Why do some antidepressants promote suicide? Psychopharmacology (Berl) 1980;90:422.FeuersteinTJ]]JackischRWhy do some antidepressants promote suicide?Psychopharmacology (Berl)19809042214. Damluji NF, Ferguson JM. Paradoxical worsening of depressive symptomatology caused by antidepressants. J Clin Psychopharmacol 1988;8:347–349.DamlujiNF]]FergusonJMParadoxical worsening of depressive symptomatology caused by antidepressants.J Clin Psychopharmacol19888347-34915. Teicher MH, Glod C, Cole JO. Emergence of intense suicidal preoccupation during fluoxetine treatment. Am J Psychiatry 1990;147:207–210.TeicherMH]]GlodC]]ColeJOEmergence of intense suicidal preoccupation during fluoxetine treatment.Am J Psychiatry1990147207-21016. Masand P, Gupta S, Dewan M. Suicidal ideation related to fluoxetine treatment. N Engl J Med 1991;324:420.MasandP]]GuptaS]]DewanMSuicidal ideation related to fluoxetine treatment.N Engl J Med199132442017. King RA, Riddle MA, Chappell PB, et al. Emergence of self-destructive phenomenon in children and adolescents during fluoxetine treatment. J Am Acad Child Adolesc Psychiatry 1991;30:179–186.KingRA]]RiddleMA]]ChappellPB&etal;Emergence of self-destructive phenomenon in children and adolescents during fluoxetine treatment.J Am Acad Child Adolesc Psychiatry199130179-18618. Wirsching WC, Van Putten T, Rosenberg J, et al. Fluoxetine, akathisia and suicidality: is there a causal connection? Arch Gen Psychiatry 1992;49:580–581.WirschingWC]]Van PuttenT]]RosenbergJ&etal;Fluoxetine, akathisia and suicidality: is there a causal connection?Arch Gen Psychiatry199249580-58119. Beasley CM Jr, Dornself BE, Bosomworth JC, et al. Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression. BMJ 1991;303:685–692.BeasleyCMJr]]DornselfBE]]BosomworthJC&etal;Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression.BMJ1991303685-69220. Aursnes I, Tvete IF, Gaasemyr J, et al. Suicide attempts in clinical trials with paroxetine randominzed against placebo. BMC Med 2005;3:14.AursnesI]]TveteIF]]GaasemyrJ&etal;Suicide attempts in clinical trials with paroxetine randominzed against placebo.BMC Med200531421. Healy D. Emergence of antidepressant induced suicidality. Primary Care Psychiatry 2000;6:23–28.HealyDEmergence of antidepressant induced suicidality.Primary Care Psychiatry2000623-2822. Reeves RR, Brister JC. Serious suicide attempt with duloxetine treatment. South Med J 2008;101:769.ReevesRR]]BristerJCSerious suicide attempt with duloxetine treatment.South Med J200810176923. Bridge JA, Iyengar S, Salary CB, et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA 2007;297:1683–1696.BridgeJA]]IyengarS]]SalaryCB&etal;Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials.JAMA20072971683-169624. Culpepper L, Davidson JR, Dietrich AJ, et al. Suicidality as a possible side effect of antidepressant treatment. Prim Care Companion J Clin Psychiatry 2004;6:79–86.CulpepperL]]DavidsonJR]]DietrichAJ&etal;Suicidality as a possible side effect of antidepressant treatment.Prim Care Companion J Clin Psychiatry2004679-8625. NBC News and News Services. FDA urges new warnings on antidepressants. May 2, 2007. Available at: http://www.msnbc.msn.com/id/18436346. Accessed December 19, 2008.26. Valenstein M, Kim HM, Ganoczy D, et al. Higher-risk periods for suicide among VA patients receiving depression treatment: prioritizing suicide prevention efforts. J Affect Disord 2009;112:50–58.ValensteinM]]KimHM]]GanoczyD&etal;Higher-risk periods for suicide among VA patients receiving depression treatment: prioritizing suicide prevention efforts.J Affect Disord200911250-5827. Hammond TA, Laughren TP, Racoosin JA. Suicide rates in short-term randomized controlled trials of newer antidepressants. J Clin Psychopharmacol 2006;26:203–207.HammondTA]]LaughrenTP]]RacoosinJASuicide rates in short-term randomized controlled trials of newer antidepressants.J Clin Psychopharmacol200626203-20728. Teicher MH, Glod CA, Cole JO. Antidepressant drugs and the emergence of suicidal tendencies. Drug Saf 1993;8:186–212.TeicherMH]]GlodCA]]ColeJOAntidepressant drugs and the emergence of suicidal tendencies.Drug Saf19938186-21229. Baldesserini RJ. Current status of antidepressants: clinical pharmacology and therapy. J Clin Psychiatry 1989;50:117–126.BaldesseriniRJCurrent status of antidepressants: clinical pharmacology and therapy.J Clin Psychiatry198950117-12630. Creaney W, Murray M, Healy D. Antidepressant induced suicidal ideation. Hum Psychopharmacol 1991;6:329–332.CreaneyW]]MurrayM]]HealyDAntidepressant induced suicidal ideation.Hum Psychopharmacol19916329-33231. Hoover CE. Additional case of suicidal ideations associated with fluoxetine. Am J Psychiatry 1990;147:1570–1571.HooverCEAdditional case of suicidal ideations associated with fluoxetine.Am J Psychiatry19901471570-157132. Harvey AT, Silkey BS, Kornstein SG, et al. Acute worsening of chronic depression during a double-blind, clinical randomized trial of antidepressant efficacy: differences by sex and menopausal status. J Clin Psychiatry 2007;68:951–958.HarveyAT]]SilkeyBS]]KornsteinSG&etal;Acute worsening of chronic depression during a double-blind, clinical randomized trial of antidepressant efficacy: differences by sex and menopausal status.J Clin Psychiatry200768951-95833. Lipinski JF Jr, Mallya G, Zimmerman P, et al. Fluoxetine-induced akathisia: clinical and theoretical implications. J Clin Psychiatry 1989;50:339–342.LipinskiJFJr]]MallyaG]]ZimmermanP&etal;Fluoxetine-induced akathisia: clinical and theoretical implications.J Clin Psychiatry198950339-34234. Gardos G, Teicher MH, Lipinski JF Jr, et al. Quantitative assessment of psychomotor activity in patients with neuroleptic-induced akathisia. Progress Neuropsychopharmacol Biol Psychiatry 1992;16:27–32.GardosG]]TeicherMH]]LipinskiJFJr&etal;Quantitative assessment of psychomotor activity in patients with neuroleptic-induced akathisia.Progress Neuropsychopharmacol Biol Psychiatry19921627-3235. Rothschild AJ, Locke CA. Reexposure to fluoxetine after serious suicide attempts by three patients: the role of akathisia. J Clin Psychiatry 1991;52:491–493.RothschildAJ]]LockeCAReexposure to fluoxetine after serious suicide attempts by three patients: the role of akathisia.J Clin Psychiatry199152491-49336. Pohl R, Yeragani VB, Balon R, et al. The jitteriness syndrome in panic disorder patients treated with antidepressants. J Clin Psychiatry 1988;49:100–104.PohlR]]YeraganiVB]]BalonR&etal;The jitteriness syndrome in panic disorder patients treated with antidepressants.J Clin Psychiatry198849100-10437. Grunze HC. Switching, induction of rapid cycling, and increased suicidality with antidepressants in bipolar patients: fact or overinterpretation? CNS Spectr 2008;13:790–795.GrunzeHCSwitching, induction of rapid cycling, and increased suicidality with antidepressants in bipolar patients: fact or overinterpretation?CNS Spectr200813790-79538. Soloff PH, George A, Nathan RS, et al. Paradoxical effects of amitriptyline on borderline patients. Am J Psychiatry 1986;143:1603–1605.SoloffPH]]GeorgeA]]NathanRS&etal;Paradoxical effects of amitriptyline on borderline patients.Am J Psychiatry19861431603-160539. Liebowitz MR, Klein DF. Interrelationship of hysteroid dysphoria and borderline personality disorder. Psychiatr Clin North Am 1981;4:67–87.LiebowitzMR]]KleinDFInterrelationship of hysteroid dysphoria and borderline personality disorder.Psychiatr Clin North Am1981467-8740. Cornelius JR, Soloff PH, Perel JM, et al. A preliminary trial of fluoxetine in refractory borderline patients. J Clin Psychopharmacol 1991;11:116–120.CorneliusJR]]SoloffPH]]PerelJM&etal;A preliminary trial of fluoxetine in refractory borderline patients.J Clin Psychopharmacol199111116-12041. Jameison GR, Wall JR. Some psychiatric aspects of suicide. Psychiatr Quart 1933;7:211–229.JameisonGR]]WallJRSome psychiatric aspects of suicide.Psychiatr Quart19337211-22942. Barraclough B, Bunch J, Nelson B, et al. A hundred cases of suicide: clinical aspects. Br J Psychiatry 1974;125:355–373.BarracloughB]]BunchJ]]NelsonB&etal;A hundred cases of suicide: clinical aspects.Br J Psychiatry1974125355-37343. Struve FA, Klein DF, Saraf KR. Electroencephalographic correlates of suicide ideation and attempts. Arch Gen Psychiatry 1972;27:363–365.StruveFA]]KleinDF]]SarafKRElectroencephalographic correlates of suicide ideation and attempts.Arch Gen Psychiatry197227363-36544. Libby AM, Brent DA, Morrato HD, et al. Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs. Am J Psychiatry 2007;164:884–891.LibbyAM]]BrentDA]]MorratoHD&etal;Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs.Am J Psychiatry2007164884-89145. Bridge JA, Greenhouse JB, Weldon AH, et al. Suicide trends among youths aged 10 to 19 years in the United States, 1996–2005. JAMA 2008;300:1025–1026.BridgeJA]]GreenhouseJB]]WeldonAH&etal;Suicide trends among youths aged 10 to 19 years in the United States, 1996–2005.JAMA20083001025-102646. Centers for Disease Control and Prevention (CDC). Suicide trends among youths and young adults aged 10–24 years: United States, 1990–2004. MMWR Morb Mortal Wkly Rep 2007;56:905–908.Centers for Disease Control and Prevention (CDC)Suicide trends among youths and young adults aged 10–24 years: United States, 1990–2004.MMWR Morb Mortal Wkly Rep200756905-90847. Sussman N. FDA warnings and suicide rates: unintended consequences. Primary Psychiatry 2008;15:22–23.SussmanNFDA warnings and suicide rates: unintended consequences.Primary Psychiatry20081522-2348. Reith DM, Edmonds L. Assessing the role of drugs in suicidal ideation and suicidality. CNS Drugs 2007;21:463–472.ReithDM]]EdmondsLAssessing the role of drugs in suicidal ideation and suicidality.CNS Drugs200721463-47249. Hall WD, Lucke J. How have the selective serotonin rekuptake inhibitor antidepressants affected suicide mortality? Aust N Z J Psychiatry 2006;40:941–950.HallWD]]LuckeJHow have the selective serotonin rekuptake inhibitor antidepressants affected suicide mortality?Aust N Z J Psychiatry200640941-95050. Mula M, Schmitz B, Sander JW. The pharmacological treatment of depression in adults with epilepsy. Expert Opin Pharmacother 2008;9:3159–3168.MulaM]]SchmitzB]]SanderJWThe pharmacological treatment of depression in adults with epilepsy.Expert Opin Pharmacother200893159-316851. Barry JJ, Ettinger AB, Friel P, et al; Advisory Group of the Epilepsy Foundation as part of its Mood Disorder. Consensus statement: the evaluation and treatment of people with epilepsy and affective disorders. Epilepsy Behav 2008;13(suppl 1):S1–S29.BarryJJ]]EttingerAB]]FrielP&etal;Advisory Group of the Epilepsy Foundation as part of its Mood DisorderConsensus statement: the evaluation and treatment of people with epilepsy and affective disorders.Epilepsy Behav200813S1-S2952. Möller HJ, Baldwin DS, Goodwin G, et al; WPA Section on Pharmacopsychiatry. Do SSRIs or antidepressants in general increase suicidality? WPA section on pharmacopsychiatry: consensus statement. Eur Arch Psychiatry Clin Neurosci 2008;258(suppl 3): 3–23.MöllerHJ]]BaldwinDS]]GoodwinG&etal;WPA Section on PharmacopsychiatryDo SSRIs or antidepressants in general increase suicidality? WPA section on pharmacopsychiatry: consensus statement.Eur Arch Psychiatry Clin Neurosci20082583-2353. Möller HJ. Is there evidence for negative effects of antidepressants on suicidality in depressive patients? A systematic review. Eur Arch Psychiatry Clin Neurosci 2006;256:476–496.MöllerHJIs there evidence for negative effects of antidepressants on suicidality in depressive patients? A systematic review.Eur Arch Psychiatry Clin Neurosci2006256476-496